Back to top

Image: Bigstock

Will Archer Daniels' Strategic Moves & Cost Savings Aid Growth?

Read MoreHide Full Article

Key Takeaways

  • ADM is optimizing structure, cutting costs, boosting efficiency and streamlining its portfolio.
  • ADM advances key pillars, expanding alternative protein and starch while adapting its structure.
  • ADM Nutrition recovers as Flavors demand lifts margins, while Health & Wellness benefits from biotics.

Archer Daniels Midland Company (ADM - Free Report) is focused on optimizing the organizational and operational structure. The company is actively managing productivity and innovation as well as aligning work to the interconnected trends in food security, health and wellbeing. ADM has been strengthening its internal controls, enhancing execution, improving operational efficiency and reducing costs, while streamlining its portfolio to sharpen core competencies and unlock long-term value.

Archer Daniels is smoothly progressing on its key strategic pillars, including optimize, drive and growth. Under the optimize pillar, the company had expanded its alternative protein capabilities and starch production. It continues to adapt to consumers’ changing nutritional preferences. Under its drive pillar, the company is adapting its organizational structure to meet operational excellence. ADM is focused on expanding its footprint in fast-growing alternative protein.

ADM has also been creating additional margin opportunities, opening up channels to customers, advancing digital technologies in areas like farmer needs, and growing its BioSolutions platform. In addition, the company is advancing key innovation initiatives in areas like health & wellness, supporting improved customer demand. It is focused on strategic simplification. 

In addition, Archer Daniels’ Nutrition segment is showing signs of recovery, led by improving performance in Human Nutrition. Management highlighted strength in the Flavors portfolio, supported by solid demand in North America and new international customer wins. Margin expansion in Flavors, driven by improved mix and pricing discipline, contributed meaningfully to profitability, while the Health & Wellness portfolio benefited from improving demand trends, including biotics.

The company is also advancing digital initiatives by pivoting toward regional, agile projects and accelerating its data and analytics capabilities, while maintaining investment in cybersecurity and network resilience. Hence, the company looks forward to investing in its portfolio to bolster growth and differentiation, including the plant digitization, operating leverage and higher marketing volumes in targeted markets.

ADM’s Price Performance, Valuation and Estimates

Archer Daniels shares have gained 12% in the past six months compared with the industry’s 6.9% growth.

Zacks Investment Research
Image Source: Zacks Investment Research

From a valuation standpoint, ADM trades at a forward price-to-earnings ratio of 16.86X compared with the industry’s average of 15.51X.

Zacks Investment Research
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for ADM’s 2026 and 2027 earnings per share (EPS) indicates year-over-year growth of 22.7% and 13.9%, respectively. The company’s EPS estimate for 2026 and 2027 has moved north in the past 30 days.

Zacks Investment Research
Image Source: Zacks Investment Research

Archer Daniels currently carries a Zacks Rank #3 (Hold).

Stocks to Consider in the Consumer Staples Space 

Freshpet, Inc. (FRPT - Free Report) , which is a pet food company, currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

The Zacks Consensus Estimate for Freshpet’s current financial-year sales indicates growth of 8.5% from the prior-year level. FRPT delivered a trailing four-quarter earnings surprise of 50%, on average.

Nomad Foods Limited (NOMD - Free Report) , which manufactures and distributes frozen foods, currently carries a Zacks Rank of 2.

The Zacks Consensus Estimate for Nomad Foods’ current financial-year earnings is expected to rise 6.2% from the year-ago reported figure. NOMD delivered a trailing four-quarter earnings surprise of 2.9%, on average.

Medifast, Inc. (MED - Free Report) , which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED missed the average earnings surprise by a sharp margin in the trailing four quarters. 

The Zacks Consensus Estimate for Medifast’s current financial-year earnings indicates growth of 30.5% from the year-ago number. 

Zacks' 7 Best Strong Buy Stocks (New Research Report)

Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free

Published in